Michio Ichimura

2.1k total citations
49 papers, 1.6k citations indexed

About

Michio Ichimura is a scholar working on Molecular Biology, Pharmacology and Organic Chemistry. According to data from OpenAlex, Michio Ichimura has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 17 papers in Pharmacology and 12 papers in Organic Chemistry. Recurrent topics in Michio Ichimura's work include Microbial Natural Products and Biosynthesis (13 papers), Adenosine and Purinergic Signaling (9 papers) and Quinazolinone synthesis and applications (5 papers). Michio Ichimura is often cited by papers focused on Microbial Natural Products and Biosynthesis (13 papers), Adenosine and Purinergic Signaling (9 papers) and Quinazolinone synthesis and applications (5 papers). Michio Ichimura collaborates with scholars based in Japan, Singapore and United States. Michio Ichimura's co-authors include Hiroshi Kase, Keiichi Takahashi, Hiromi Nonaka, ISAMI TAKAHASHI, Akihisa Mori, Tomomi Shindou, Hirofumi Nakano, Makoto Morimoto, Tohru Yasuzawa and Hiroshi Sano and has published in prestigious journals such as The Journal of Physiology, Scientific Reports and Biochemical Journal.

In The Last Decade

Michio Ichimura

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michio Ichimura Japan 23 928 594 372 296 264 49 1.6k
Gina H. Lu United States 21 1.1k 1.2× 460 0.8× 594 1.6× 101 0.3× 388 1.5× 32 2.0k
Olga Bruno Italy 30 1.1k 1.1× 1.8k 3.0× 95 0.3× 525 1.8× 98 0.4× 130 2.8k
Hamideh Zarrinmayeh United States 23 927 1.0× 725 1.2× 109 0.3× 136 0.5× 286 1.1× 38 1.5k
Andrew W. Stamford United States 22 604 0.7× 479 0.8× 245 0.7× 187 0.6× 245 0.9× 51 1.5k
Paul Jackson United States 22 809 0.9× 407 0.7× 142 0.4× 84 0.3× 509 1.9× 43 1.7k
David J. Wustrow United States 20 746 0.8× 611 1.0× 61 0.2× 77 0.3× 491 1.9× 54 1.7k
Andrew O. Stewart United States 27 826 0.9× 757 1.3× 76 0.2× 315 1.1× 290 1.1× 53 1.8k
Philip A. S. Lowden United Kingdom 14 966 1.0× 227 0.4× 44 0.1× 196 0.7× 527 2.0× 23 1.4k
Carola Gallo‐Rodriguez Argentina 24 1.1k 1.2× 963 1.6× 847 2.3× 50 0.2× 227 0.9× 48 1.9k
Robert J. Mourey United States 18 881 0.9× 236 0.4× 63 0.2× 53 0.2× 214 0.8× 25 1.3k

Countries citing papers authored by Michio Ichimura

Since Specialization
Citations

This map shows the geographic impact of Michio Ichimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michio Ichimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michio Ichimura more than expected).

Fields of papers citing papers by Michio Ichimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michio Ichimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michio Ichimura. The network helps show where Michio Ichimura may publish in the future.

Co-authorship network of co-authors of Michio Ichimura

This figure shows the co-authorship network connecting the top 25 collaborators of Michio Ichimura. A scholar is included among the top collaborators of Michio Ichimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michio Ichimura. Michio Ichimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Katayama, Yuki, Keiko Suzuki, Kazuo Aisaka, et al.. (2019). Creation of haemoglobin A1c direct oxidase from fructosyl peptide oxidase by combined structure-based site specific mutagenesis and random mutagenesis. Scientific Reports. 9(1). 942–942. 18 indexed citations
2.
Hirose, Ryo, et al.. (2008). Differential Effects of PDE4 Inhibitors on Cortical Neurons and T-Lymphocytes. Journal of Pharmacological Sciences. 106(2). 310–317. 7 indexed citations
3.
Onodera, Hideyuki, Masami Kaneko, Yuichi Takahashi, et al.. (2008). Conformational significance of EH21A1–A4, phenolic derivatives of geldanamycin, for Hsp90 inhibitory activity. Bioorganic & Medicinal Chemistry Letters. 18(5). 1588–1591. 17 indexed citations
4.
Hirose, Ryo, Haruhiko Manabe, Hiromi Nonaka, et al.. (2007). Correlation between emetic effect of phosphodiesterase 4 inhibitors and their occupation of the high-affinity rolipram binding site in Suncus murinus brain. European Journal of Pharmacology. 573(1-3). 93–99. 27 indexed citations
7.
Ohta, Emi, et al.. (2003). Piericidins C5 and C6: new 4-pyridinol compounds produced by Streptomyces sp. and Nocardioides sp.. Bioorganic & Medicinal Chemistry. 11(21). 4569–4575. 22 indexed citations
8.
Shindou, Tomomi, Hiromi Nonaka, Peter J. Richardson, et al.. (2002). Presynaptic adenosine A2A receptors enhance GABAergic synaptic transmission via a cyclic AMP dependent mechanism in the rat globus pallidus. British Journal of Pharmacology. 136(2). 296–302. 61 indexed citations
9.
Nonaka, Hiromi, et al.. (2002). KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist. European Journal of Pharmacology. 444(3). 133–141. 26 indexed citations
10.
Shindou, Tomomi, Akihisa Mori, Hiroshi Kase, & Michio Ichimura. (2001). Adenosine A2A receptor enhances GABAA‐mediated IPSCs in the rat globus pallidus. The Journal of Physiology. 532(2). 423–434. 55 indexed citations
11.
Ito, Michihiko, Ryo Hirose, Michio Ichimura, et al.. (2000). Isoforms of JSAP1 scaffold protein generated through alternative splicing. Gene. 255(2). 229–234. 32 indexed citations
12.
Nonaka, Hiromi, Shizuo Otaki, Etsuo Ohshima, et al.. (1998). Unique binding pocket for KW-4679 in the histamine H1 receptor. European Journal of Pharmacology. 345(1). 111–117. 59 indexed citations
13.
Manabe, Haruhiko, et al.. (1997). Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor. European Journal of Pharmacology. 332(1). 97–107. 17 indexed citations
14.
Mori, Tatsuya, et al.. (1996). Effect of Terfenadine and KW-4679, a Novel Antiallergic Compound, on Action Potential of Guinea Pig Ventricular Myocytes. The Japanese Journal of Pharmacology. 70(2). 199–202. 6 indexed citations
15.
Nonaka, Hiromi, Michio Ichimura, Masami Takeda, et al.. (1994). KF17837 ((E)-8-(3,4-dimethoxystyryl)-1,3-dipropyl-7-methylxanthine) a potent and selective adenosine A2 receptor antagonist. European Journal of Pharmacology Molecular Pharmacology. 267(3). 335–341. 67 indexed citations
16.
Hamakubo, Takao, Hiroaki Furuta, Michio Ichimura, et al.. (1992). A Na pump inhibitor from bovine posterior pituitary: Purification, structure determination and its cardiovascular effect in rat. Biochemical and Biophysical Research Communications. 189(2). 691–696. 8 indexed citations
17.
Yasuzawa, Tohru, Yutaka Saitoh, Michio Ichimura, ISAMI TAKAHASHI, & Hiroshi Sano. (1991). Structure of duocarmycin SA, a potent antitumor antibiotic.. The Journal of Antibiotics. 44(4). 445–447. 44 indexed citations
18.
Ogawa, T., et al.. (1989). New antitumor antibiotics, duocarmycins B1 and B2.. The Journal of Antibiotics. 42(8). 1299–1301. 52 indexed citations
19.
Ichimura, Michio, Kozo Asano, Isao Kawamoto, et al.. (1988). DC89-A1, a new antitumor antibiotic from Streptomyces.. The Journal of Antibiotics. 41(9). 1285–1288. 59 indexed citations
20.
Ichimura, Michio, et al.. (1987). CV-1, a new antibiotic produced by a strain of Streptomyces sp. I. Fermentation, isolation and biological properties of the antibiotic.. The Journal of Antibiotics. 40(6). 723–726. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026